Description Format Author(s) References
Meta-analytic dataset of 4 trials of Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices.
Dataset used to illustrate power estimator ipd.sep
study | Name of trial |
n0 | Control group sample size |
n1 | Beta-adrenergic-antagonist group sample size |
bleed0 | Control group number of bleeding events at 2 year follow-up |
bleed1 | Beta-adrenergic-antagonist group number of bleeding events at 2 year follow-up |
age0 | Control group mean age |
age1 | Beta-adrenergic-antagonist group mean age |
age.s20 | Control group variance age |
age.s21 | Beta-adrenergic-antagonist group variance age |
male0 | Control group sample proportion male |
male1 | Beta-adrenergic-antagonist sample proportion male |
drug | Beta-adrenergic-antagonist studied |
S. Kovalchik s.a.kovalchik@gmail.com
Poynard, T, Cales, P, Pasta, L, Ideo, G, Pascal, J P, Pagliaro, L, Lebrec, D, (1991), Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group, NEJM, 324, 1532-8.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.